Establishment Labs Holdings, Inc. Stock News

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies 2025 London Healthcare Conference. Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, are scheduled...

Establishment Labs Holdings Inc. ( ESTA ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Rajbir Denhoy - Chief Financial Officer Filippo Caldini - CEO & Director Conference Call Participants Anthony Petrone - Mizuho Americas LLC Joshua Jennings - TD Cowen, Research Division K. Gong - JPMorgan Chase & Co, Research Division Sam Eiber - BTIG, LLC, Research Division Mason C...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2025. Third Quarter Highlights and Outlook (Unaudited) Third quarter worldwide revenue of $53.8 million,...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2025, before the market opens on Wednesday, November 5, 2025, and will host a conference call at 8:30 am...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, noted the publication of “The 3-Year Results of a 100-Patient Prospective Study of Safety and Effectiveness of Mia Femtech” in the Aesthetic Surgery Journal. The study showed a ver...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced publication of its 2025 Post-Market Surveillance (PMS) Report. The report is being released ahead of the annual meeting of the American Society of Plastic Surgeons held O...

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Fillipo Peter Caldini - CEO & Director Rajbir Singh Denhoy - Chief Financial Officer Conference Call Participants Anthony Charles Petrone - Mizuho Americas LLC Joshua Thomas Jennings - TD Cowen, Research Division K. Gong - JPMorgan Chase & Co, Research Division Mason O...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2025. Second Quarter Highlights and Outlook (Unaudited) Second quarter worldwide revenue of $51.3 million, a...